A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy
Clinical trial NCT07065786 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07065786
- Sponsor
- Zhongda Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-01
- Primary completion
- 2026-01-01
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.